Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000732042 | SCV000859918 | pathogenic | not provided | 2018-02-21 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV004768619 | SCV005380375 | pathogenic | Adrenoleukodystrophy | 2024-08-22 | criteria provided, single submitter | clinical testing | Variant summary: ABCD1 c.1076_1077delAG (p.Glu359ValfsX41) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant was absent in 182608 control chromosomes. c.1076_1077delAG has been reported in the literature in at-least one individual affected with Adrenoleukodystrophy (example: Gomez Lira_1999). The following publication has been ascertained in the context of this evaluation (PMID: 10426149). ClinVar contains an entry for this variant (Variation ID: 596275). Based on the evidence outlined above, the variant was classified as pathogenic. |